1.600
−11,11%
2026-10-16
Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -3844.5% | -1207.4% | 2 / 3 | -78.6% | +10.66 pp | -3.22 pp | +0.1% | -1.20 | — | 109 | −78,6% | −3,5 | −3.844,5% | — | -1.37 | — |
| Pts | 0 | 0 | 8 | 0 | 12 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 1.600 (close price on 2026-10-16)EPS (TTM): −9,2
Financial charts
1.Revenue & growth
VND bn109Q2/26
1.Revenue & growth
VND bn109Q2/26
2.Profit & growth
VND bn-3,62Q2/26
3.Profit mix (Penman)
VND bn5,30Q2/26
4.Margins & cost structure
%6.7%Q2/26
5.Returns & cash cycle
% · days
6.Earnings quality & cash
VND bn67,7Q2/26
7.Asset structure
VND bn1.023Q2/26
8.Funding & debt health
VND bn · times1.023Q2/26
9.Revenue backlog
VND bn8,47Q2/26
10.Valuation
times · %-158,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-61Q2/26
Adjusted EPS growth, latest quarter
-3984%
Average adjusted EPS growth, 3 quarters
-3984%
averaged over 1 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26